Workflow
Cannabis
icon
Search documents
Vireo Growth Inc. Announces Launch of Adult-Use Cannabis Sales in Minnesota
Globenewswire· 2025-09-16 13:15
Company Overview - Vireo Growth Inc. has commenced the sale of adult-use cannabis at all eight Green Goods® dispensaries in Minnesota as of September 16, 2025 [1][2] - The company has been operating in Minnesota's medical cannabis market since 2014, serving tens of thousands of patients [2][4] - Vireo aims to expand access, improve product quality, and support the transition to a sustainable adult-use market in Minnesota [2][4] Market Impact - The launch of the adult-use cannabis market in Minnesota, with a population of 5.7 million, is expected to drive strong organic revenue growth for Vireo [1][2] - Vireo is one of the state's licensed adult-use cannabis cultivators and retailers, positioning itself to benefit from the new market dynamics [2][4] Product Offering - Green Goods® dispensaries offer a comprehensive range of medical and adult-use cannabis products, including flower, pre-rolls, edibles, and beverages [3][4] - The dispensaries are strategically located in key areas such as Minneapolis, Blaine, Bloomington, Burnsville, Duluth, Moorhead, Rochester, and Woodbury [3] Leadership Commentary - Amber Shimpa, President of Vireo, expressed pride in making products available to all Minnesotans while maintaining commitment to medical patients [3] - Alexandra Breant, Head of Market in Minnesota, highlighted the significance of this milestone in expanding access and building community [3]
Glow Lifetech Expands MOD and .decimal brands in Saskatchewan Market, Advancing National Growth Strategy
Newsfile· 2025-09-16 11:30
Core Insights - Glow Lifetech Corp is expanding its MOD™ and .decimal™ brands into the Saskatchewan cannabis retail market, marking a significant step in its national growth strategy [1][2][3] Expansion Strategy - The expansion into Saskatchewan follows successful entries into Ontario and New Brunswick, with the company securing 10 product listings in Saskatchewan, which will create a new long-term revenue stream [2][4] - The company aims to leverage its success in Ontario to scale its operations nationally in a disciplined manner [2][3] Commercial Momentum - The Saskatchewan expansion is part of a broader strategy that includes deepening penetration in Ontario while entering new provinces [4][5] - Recent commercial progress indicates strong momentum, with MOD™ being established among Ontario's leading oil brands [4][5] Business Model and Innovation - Glow Lifetech's disciplined growth strategy combines expanded retail distribution, new provincial launches, and ongoing product innovation, reinforcing the fundamentals of the business [5] - The company's scalable model positions it for sustainable growth and long-term value creation [5]
X @Forbes
Forbes· 2025-09-16 11:00
WATCH: How Cheech & Chong Turned Their Legacy Into A $100 Million Cannabis Empire https://t.co/uS8VzUu0Wq https://t.co/QN6qtN7Ird ...
Cresco Labs Opens Sunnyside Proctorville, Strengthening Ohio Market Leadership
Businesswire· 2025-09-16 10:30
CHICAGO--(BUSINESS WIRE)--Cresco Labs Opens Sunnyside Proctorville, Strengthening Ohio Market Leadership. ...
Tilray Brands’ Breckenridge Distillery And Its Partner Denver Broncos Enters Fifth Year of Partnership
Yahoo Finance· 2025-09-15 12:17
Group 1 - Tilray Brands, Inc. is recognized as one of the 12 Best NASDAQ Penny Stocks to Buy According to Hedge Funds [1] - The partnership between Breckenridge Distillery and the Denver Broncos marks its fifth year, introducing a new lineup of limited-edition spirits [2][3] - The new collection includes unique products such as Broncos Honey Whiskey and Vodka Creamsicle Seltzer, celebrating Colorado and the Broncos' legacy [3][4] Group 2 - Jefferies analyst Kaumil Gajrawala raised the price target for Tilray Brands from $1.50 to $2, maintaining a Buy rating due to positive developments in cannabis regulation [5] - Tilray Brands operates in the lifestyle consumer products sector, focusing on medical cannabis through four segments: Beverage, Cannabis, Distribution, and Wellness [6]
12 Best Marijuana Stocks to Buy According to Analysts
Insider Monkey· 2025-09-15 11:21
Industry Overview - The U.S. administration is considering reclassifying marijuana from Schedule I to Schedule III under the Controlled Substances Act, which could significantly impact the marijuana industry by allowing businesses to access standard banking and reducing their effective tax rates [2] - Currently, marijuana's Schedule I classification limits business deductions under Section 280E of the federal tax code, which could change with reclassification, potentially increasing profitability and attracting institutional investors [2] Analyst Insights - TD Cowen analyst Jaret Seiberg suggests that former President Trump may revive efforts to move cannabis to Schedule III, allowing for government regulation [3] Best Marijuana Stocks - **Aurora Cannabis Inc. (NASDAQ: ACB)**: Analysts project an upside potential of 4.55%. The company launched the Physician Experience Platform (PEP) to provide healthcare professionals with access to clinical insights on medicinal cannabis treatments [8] - **Turning Point Brands, Inc. (NYSE: TPB)**: Analysts project an upside potential of 5.47%. The company launched Stoker's Fine Cut Wintergreen in a compact can, responding to consumer demand and enhancing its moist smokeless tobacco line [9][10] - **The Scotts Miracle-Gro Company (NYSE: SMG)**: Analysts project an upside potential of 12.90%. The company made significant strides in sustainability, including reducing water usage for greenhouse irrigation by over 50% and achieving 100% recyclable packaging for its products [11][12]
Verano Holdings Corp. Announces Proposed Redomicile of Parent Company from British Columbia to Nevada
Globenewswire· 2025-09-15 11:00
Core Viewpoint - Verano Holdings Corp. plans to redomicile from British Columbia, Canada, to Nevada, aiming to better align with its U.S. operations and streamline its organizational structure [1][2][3]. Group 1: Redomiciling Plan - The Board of Directors has approved a plan to seek shareholder approval for the redomiciling process [1][5]. - The move is expected to enhance shareholder value and create potential growth catalysts for the company [3]. - Upon completion, existing subordinate voting shares will be exchanged on a one-for-one basis for Nevada Common Stock [4]. Group 2: Business Operations - The redomiciling is not anticipated to materially impact Verano's existing manufacturing and retail operations across 13 U.S. states [3]. - The corporate headquarters will remain in Chicago, Illinois, ensuring continuity in operations [3]. Group 3: Shareholder Engagement - A preliminary proxy statement was filed to facilitate a special meeting for shareholders to consider the proposed plan [5]. - The Board retains the discretion to halt the arrangement even after receiving shareholder approval [5]. Group 4: Company Overview - Verano is a leading multi-state cannabis operator with a focus on providing high-quality cannabis products and a superior shopping experience [7]. - The company operates 15 production facilities with over 1.1 million square feet of cultivation capacity across 13 U.S. states [7].
X @Forbes
Forbes· 2025-09-15 04:00
WATCH: How Cheech & Chong Turned Their Legacy Into A $100 Million Cannabis Empire https://t.co/1yvDSIm3b7 https://t.co/bCM4gieIXE ...
12 Best NASDAQ Penny Stocks to Buy According to Hedge Funds
Insider Monkey· 2025-09-14 18:50
Core Insights - The article discusses the performance of active U.S. small-cap managers, highlighting their strong long-term performance relative to the Russell 2000 index, particularly during value stock-led periods [2][3][4] Small-Cap Management Performance - Active small-cap managers outperformed the Russell 2000 index 58% of the time over rolling 5-year periods, with an 82% success rate during value-led periods and only 15% during growth-led periods [3] - 65% of the analyzed periods were value-led, indicating a favorable environment for active management [3] - When the Russell 2000's annualized 5-year return was 5% or lower, value stocks outperformed growth stocks only 48% of the time, but they averaged higher returns [4] - In periods with annualized 5-year returns between 5-10%, value stocks exceeded growth stocks 70% of the time, relevant as small-cap returns are expected to be in this range over the next five years [4] Hedge Fund Interest in Penny Stocks - The article lists the 12 best NASDAQ penny stocks to buy according to hedge funds, emphasizing the strategy of imitating top hedge fund picks to outperform the market [5][9] - The methodology involved shortlisting the largest companies trading under $5 on the NASDAQ and ranking them by the number of hedge fund holders [7][8] Company Highlights - **Prospect Capital Corporation (NASDAQ:PSEC)**: - Price as of September 12: $2.79, with 11 hedge fund holders [10] - Recently completed an $18 million investment in The Ridge, a physician-led addiction treatment facility [10][11] - The company has a net debt to total assets ratio of 30.4%, indicating high leverage, and is strategically exiting a real estate investment yielding 4.5% [13][14] - **Tilray Brands, Inc. (NASDAQ:TLRY)**: - Price as of September 12: $1.12, with 12 hedge fund holders [15] - Recently partnered with the Denver Broncos to launch a new lineup of spirits, celebrating their ongoing collaboration [15][16] - Analyst Kaumil Gajrawala raised the price target from $1.50 to $2, maintaining a Buy rating, influenced by the rescheduling of cannabis regulations in the U.S. [19][20]
From States to Federal Reform: The Cannabis Sector’s Path Forward
Marijuana Stocks | Cannabis Investments And News. Roots Of A Budding Industry.™· 2025-09-14 14:00
Core Insights - The U.S. cannabis industry is rapidly maturing with larger markets and more efficient operators, despite ongoing federal restrictions on full legalization [1] - Federal policy changes are gradually occurring, indicating a potential long-term shift in the cannabis landscape [2] - State-level leaders are crucial for monitoring growth and investment opportunities in the cannabis sector [1][23] Federal Legalization Efforts - Cannabis remains illegal federally, but the Department of Justice is considering rescheduling it from Schedule I to Schedule III, which would acknowledge its medical use and lower abuse risk classification [2] - This rescheduling would not legalize recreational use but would ease research restrictions and reduce tax burdens under Section 280E [2] Banking Reform - The SAFER Banking Act aims to normalize banking for cannabis businesses, reducing cash usage and improving transparency [4] - This reform would provide legal protection for banks, allowing more institutions to serve the cannabis industry, thus lowering costs and enhancing capital access for operators [4] Growth Projections - Cannabis sales are projected to reach approximately $31.4 billion in 2024, with steady double-digit growth expected into 2025 [5] - By 2030, total sales are anticipated to exceed $67 billion, with some estimates reaching nearly $87 billion by 2035, contingent on expanded legalization and consumer shifts from the illicit market [5] State-Level Success Stories - **Michigan**: Market surpassed $3 billion in 2024, with strong demand despite falling prices due to competition [6] - **Missouri**: Sales reached $1.46 billion in 2024, driven by streamlined licensing and moderate taxes [7] - **Illinois**: Sales exceeded $2 billion in 2024, with tax revenues over $490 million, supported by social equity programs and strong urban demand [8] - **New Jersey**: Revenues surpassed $2 billion, benefiting from early access for medical operators [9] - **Florida**: Medical-only market with nearly 900,000 registered patients, showing significant sales potential [10] - **New York**: Sales on track to reach the billion-dollar mark, with improving licensing and supply chains [11] Tax Revenues and Community Impact - Since 2014, adult-use states have collected nearly $25 billion in tax revenue, supporting education, public health, and social equity initiatives [12] - Legal markets reduce illicit activity and provide consumers with tested and labeled products, benefiting communities through job creation and reinvestment [12] Future Considerations - Federal rescheduling and the SAFER Banking Act could significantly improve industry fundamentals [13] - State ballot measures and legislative sessions will influence growth trajectories, with tax debates being crucial for margins and expansion [13] Leading Companies - **Trulieve Cannabis Corp.**: Dominates Florida's medical market with over 190 dispensaries, reporting billions in annual revenue [15] - **Curaleaf Holdings Inc.**: Operates over 150 dispensaries across high-growth states, with strong revenue growth exceeding a billion dollars [17] - **Green Thumb Industries Inc.**: Operates more than 90 dispensaries, known for strong consumer brands and solid revenues above $1 billion annually [19][20] Investor Considerations - Investors should focus on efficient operators, evaluate tax structures, and consider municipal support [22] - Strong brands with consistent quality are likely to gain market share, and balance sheets will be critical post-280E reform [22]